Follow The Filings

UTI Universal Technical Institute

Universal Technical Institute earnings company data as of 4:48 AM ET 10/22

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 18 Nov EPS 0.33 — —
Rev — — —

Insider trades

Open-market buys and sales by UTI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All UTI insider trades
  • $31.1M bought by 2 insiders
  • $135M sold by 11 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Robert Thomas Devincenzi Director
    Buy
    $20K 1,000 shares at $19.68 +0.7% to stake
    Traded Sep 28 Filed Sep 30
    ↗
  2. Robert Thomas Devincenzi Director
    Buy
    $20K 1,000 shares at $19.83 +0.7% to stake
    Traded Sep 21 Filed Sep 23
    ↗
  3. Robert Thomas Devincenzi Director
    Buy
    $22K 1,000 shares at $21.80 +0.7% to stake
    Traded Aug 27 Filed Aug 31
    ↗
  4. Robert Thomas Devincenzi Director
    Buy
    $22K 1,000 shares at $21.77 +0.7% to stake
    Traded Aug 25 Filed Aug 27
    ↗
  5. Robert Thomas Devincenzi Director
    Buy
    $26K 1,000 shares at $25.95 +0.7% to stake
    Traded Aug 12 Filed Aug 14
    ↗
  6. Robert Thomas Devincenzi Director
    Buy
    $226K 8,000 shares at $28.21 +5.7% to stake
    Traded Aug 10 Filed Aug 12
    ↗
  7. Jerome Alan Grant CEO
    Sale
    $3.9M 94,500 shares at $41.40 22% of stake
    Traded Jun 29 Filed Jun 30
    ↗
  8. Kevin Prehn Concorde Division President
    Sale
    $182K 4,545 shares at $40.00 14% of stake
    Traded Jun 22 Filed Jun 24
    ↗
  9. Coliseum Capital Management, LLC Director, +4 joint filers
    Sale
    $124M 3,000,000 shares at $41.40 76% of stake
    Traded Jun 8 Filed Jun 10
    ↗
  10. Christine Kline Senior Vice President and CAO
    Sale
    $155K 3,500 shares at $44.42 7.5% of stake
    Traded Jun 5 Filed Jun 8
    ↗
  11. Linda J Srere Director
    Sale
    $549K 15,000 shares at $36.59 11% of stake
    Traded May 11 Filed May 13
    ↗
  12. Christopher E. Kevane EVP and Chief Legal Officer
    Sale
    $888K 23,654 shares at $37.55 22% of stake
    Traded Mar 27 Filed Mar 31
    ↗
  13. George W. Brochick Director
    Sale
    $183K 5,000 shares at $36.59 15% of stake
    Traded Mar 17 Filed Mar 18
    ↗
  14. Shannon Lei Okinaka Director
    Sale
    $347K 10,000 shares at $34.74 34% of stake
    Traded Mar 6 Filed Mar 9
    ↗
  15. Todd A Hitchcock COO
    Sale
    $616K 16,500 shares at $37.33 14% of stake
    Traded Mar 4 Filed Mar 6
    ↗

Also filed in the last 12 months, not counted as buying or selling: 36 share withholdings for taxes, 27 stock grants, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
8-K 1.01,2.03,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
8-K 5.05 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.